BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16585198)

  • 1. ERBB2-mediated transcriptional up-regulation of the alpha5beta1 integrin fibronectin receptor promotes tumor cell survival under adverse conditions.
    Spangenberg C; Lausch EU; Trost TM; Prawitt D; May A; Keppler R; Fees SA; Reutzel D; Bell C; Schmitt S; Schiffer IB; Weber A; Brenner W; Hermes M; Sahin U; Türeci O; Koelbl H; Hengstler JG; Zabel BU
    Cancer Res; 2006 Apr; 66(7):3715-25. PubMed ID: 16585198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premature senescence is a primary fail-safe mechanism of ERBB2-driven tumorigenesis in breast carcinoma cells.
    Trost TM; Lausch EU; Fees SA; Schmitt S; Enklaar T; Reutzel D; Brixel LR; Schmidtke P; Maringer M; Schiffer IB; Heimerdinger CK; Hengstler JG; Fritz G; Bockamp EO; Prawitt D; Zabel BU; Spangenberg C
    Cancer Res; 2005 Feb; 65(3):840-9. PubMed ID: 15705882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of survivin by ErbB2 signaling: therapeutic implications for ErbB2-overexpressing breast cancers.
    Xia W; Bisi J; Strum J; Liu L; Carrick K; Graham KM; Treece AL; Hardwicke MA; Dush M; Liao Q; Westlund RE; Zhao S; Bacus S; Spector NL
    Cancer Res; 2006 Feb; 66(3):1640-7. PubMed ID: 16452223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A negative feedback regulatory loop associates the tyrosine kinase receptor ERBB2 and the transcription factor GATA4 in breast cancer cells.
    Hua G; Zhu B; Rosa F; Deblon N; Adélaïde J; Kahn-Perlès B; Birnbaum D; Imbert J
    Mol Cancer Res; 2009 Mar; 7(3):402-14. PubMed ID: 19276186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible factor-1alpha mediates oral squamous cell carcinoma invasion via upregulation of alpha5 integrin and fibronectin.
    Ryu MH; Park HM; Chung J; Lee CH; Park HR
    Biochem Biophys Res Commun; 2010 Feb; 393(1):11-5. PubMed ID: 20097172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mechanism for integrin-mediated ras activation in breast carcinoma cells: the alpha6beta4 integrin regulates ErbB2 translation and transactivates epidermal growth factor receptor/ErbB2 signaling.
    Yoon SO; Shin S; Lipscomb EA
    Cancer Res; 2006 Mar; 66(5):2732-9. PubMed ID: 16510594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.
    Kapoor GS; Kapitonov D; O'Rourke DM
    Cancer Res; 2004 Sep; 64(18):6444-52. PubMed ID: 15374953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro.
    Ma C; Lin H; Leonard SS; Shi X; Ye J; Luo J
    Oncogene; 2003 Aug; 22(34):5281-90. PubMed ID: 12917629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor 1alpha mediates anoikis resistance via suppression of alpha5 integrin.
    Rohwer N; Welzel M; Daskalow K; Pfander D; Wiedenmann B; Detjen K; Cramer T
    Cancer Res; 2008 Dec; 68(24):10113-20. PubMed ID: 19074877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth.
    Zhao YH; Zhou M; Liu H; Ding Y; Khong HT; Yu D; Fodstad O; Tan M
    Oncogene; 2009 Oct; 28(42):3689-701. PubMed ID: 19668225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha6beta1 integrin induces proteasome-mediated cleavage of erbB2 in breast cancer cells.
    Shimizu H; Seiki T; Asada M; Yoshimatsu K; Koyama N
    Oncogene; 2003 Feb; 22(6):831-9. PubMed ID: 12584562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia.
    Kaidi A; Qualtrough D; Williams AC; Paraskeva C
    Cancer Res; 2006 Jul; 66(13):6683-91. PubMed ID: 16818642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors.
    Tan M; Li P; Sun M; Yin G; Yu D
    Oncogene; 2006 Jun; 25(23):3286-95. PubMed ID: 16407820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased integrin alpha5beta1 heterodimer formation and reduced c-Jun expression are involved in integrin beta1 overexpression-mediated cell growth arrest.
    Fang Z; Yao W; Fu Y; Wang LY; Li Z; Yang Y; Shi Y; Qiu S; Fan J; Zha X
    J Cell Biochem; 2010 Feb; 109(2):383-95. PubMed ID: 19960514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of transferrin receptor blockade on cancer cell proliferation and hypoxia-inducible factor function and their differential regulation by ascorbate.
    Jones DT; Trowbridge IS; Harris AL
    Cancer Res; 2006 Mar; 66(5):2749-56. PubMed ID: 16510596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. alpha1,3 fucosyltransferase-VII up-regulates the mRNA of alpha5 integrin and its biological function.
    Wang QY; Zhang Y; Shen ZH; Chen HL
    J Cell Biochem; 2008 Aug; 104(6):2078-90. PubMed ID: 18452157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ; Hilger AM; Murthy S; Rae JM; Chinnaiyan AM; El-Ashry D
    Cancer Res; 2006 Apr; 66(7):3903-11. PubMed ID: 16585219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia-inducible factor-1 in human breast and prostate cancer.
    Kimbro KS; Simons JW
    Endocr Relat Cancer; 2006 Sep; 13(3):739-49. PubMed ID: 16954428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta 4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis.
    Guo W; Pylayeva Y; Pepe A; Yoshioka T; Muller WJ; Inghirami G; Giancotti FG
    Cell; 2006 Aug; 126(3):489-502. PubMed ID: 16901783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
    Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.